Dysphagia Knowledge Hub — 吞嚥困難知識庫

Case Study 3: Parkinson’s Disease and Progressive Dysphagia

Patient Presentation

Mrs. T is a 68-year-old retired nurse with a 7-year history of Parkinson’s disease (PD), currently Hoehn & Yahr Stage 3. She is referred by her neurologist following a 3-month history of worsening swallowing difficulties, a 4 kg weight loss, and one episode of aspiration pneumonia 6 weeks prior requiring inpatient antibiotic treatment.

Her husband has noted meal times now take 45–60 minutes (previously 20 minutes), that she occasionally pockets food in her cheeks, and that she drools during meals. She reports that swallowing feels “much harder” and that she needs to concentrate intensely to initiate each swallow.

Parkinson’s medications: Levodopa/carbidopa (Sinemet 25/100), three times daily at 07:00, 13:00, and 19:00. The neurologist notes she has clear “off” periods in the late morning and early evening.

Nutrition: Weight 48 kg (usual weight 52 kg over 6 months); BMI 18.2 kg/m². MNA-SF score: 7 (malnourished). Dietitian referral made.


Clinical Background: Dysphagia in Parkinson’s Disease

Parkinson’s disease affects swallowing at multiple levels. Unlike stroke (acute onset, often with partial recovery), PD-related dysphagia is typically:


Assessment

EAT-10: Score 18 (moderate-severe range — items 1, 3, 4, 7, 8, 9, 10 all elevated)

GUSS: Performed during a medication “on” state (60 min post-levodopa dose):

The SLT noted that the patient’s husband reported swallowing was “much worse” two hours before each Sinemet dose — typical of motor fluctuations affecting swallowing.


VFSS Findings

VFSS was performed during an “off” period to characterise worst-case swallowing:


Management Plan

Dietary prescription:

Medication timing:

Rehabilitation:

Nutrition:


3-Month Review


Learning Points

  1. Medication timing is part of dysphagia management in PD: Scheduling meals 60–90 minutes after levodopa doses can dramatically improve swallowing safety.
  2. VFSS in “off” state reveals true severity: Assess during the worst functional period to inform decisions about tube feeding and aspiration risk.
  3. EMST improves cough strength: Protecting the airway through cough is as important as safe swallowing in PD.
  4. LSVT has swallowing benefits: Pharyngeal swallowing amplitude and hyoid excursion improve with LSVT in PD patients.

References

  1. Hoehn MM, Yahr MD (1967). Parkinsonism: onset, progression and mortality. Neurology, 17(5):427–42. PMID: 6067254
  2. Mahler LA, et al. (2015). Effects of LSVT LOUD on children with autism and Down syndrome. Am J Speech Lang Pathol, 24(3):651–67. DOI: 10.1044/2015_AJSLP-14-0106
  3. Wheeler-Hegland K, et al. (2014). Evidence-based systematic review: oropharyngeal dysphagia behavioral treatments. J Rehabil Res Dev, 46(2):175–94. DOI: 10.1682/JRRD.2007.10.0171
  4. Troche MS, et al. (2010). Aspiration and swallowing in Parkinson disease and rehabilitation with EMST. Neurology, 75(21):1912–9. DOI: 10.1212/WNL.0b013e3181fef115